Kardia Therapeutics Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Kardia Therapeutics General Information

Description

Developer of a research-stage biotechnology platform designed to focus on the development of cardiac regenerative treatments. The company's platform emphasizes in the areas of myocardial infarction and heart failure by using a three-way related approaches namely, Adult Cardiac Progenitor Cell Therapy, Stem Cell Optimization Technologies and Homing-Growth Factor Therapies, enabling physicians to avail significantly improved health outcomes compared to existing treatments.

Contact Information

Website
www.kardiatherapeutics.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 1709 Dryden Road
  • Suite 910
  • Houston, TX 77030
  • United States
+1 (713) 000-0000
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Vertical(s)
TMT, Life Sciences
Corporate Office
  • 1709 Dryden Road
  • Suite 910
  • Houston, TX 77030
  • United States
+1 (713) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kardia Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 01-Oct-2018 Completed Out of Business
4. Early Stage VC Completed Startup
3. Grant 01-Jan-2007 00.000 Completed Startup
2. Grant 01-Jan-2005 $526K Completed Startup
1. Grant 01-Jan-2004 $100K Completed Startup
To view Kardia Therapeutics’s complete valuation and funding history, request access »

Ready to get started?

Request a free trial

Kardia Therapeutics FAQs

  • When was Kardia Therapeutics founded?

    Kardia Therapeutics was founded in 2002.

  • Who is the founder of Kardia Therapeutics?

    Royal Brompton is the founder of Kardia Therapeutics.

  • Where is Kardia Therapeutics headquartered?

    Kardia Therapeutics is headquartered in Houston, TX.

  • What industry is Kardia Therapeutics in?

    Kardia Therapeutics’s primary industry is Biotechnology.

  • Is Kardia Therapeutics a private or public company?

    Kardia Therapeutics is a Private company.

  • What is Kardia Therapeutics’s current revenue?

    The current revenue for Kardia Therapeutics is 000000.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »